0
     

Report Added
Report already added
Sleep Aids in the United Arab Emirates

Sleep Aids in the United Arab Emirates

In 2018, sleep aids recorded a decline in value sales terms, due to a slowdown in the economy, limited brand availability and lack of awareness about the brands present. The usage of sleep aids is historically quite limited, due to low awareness of the products and the results they can achieve. Sleep aids are often confused with their Rx versions, which are prescribed by doctors. Therefore, products related to aiding sleep are usually avoided, and natural treatments such as eating well and exerc...

Sleep Aids in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
SLEEP AIDS IN THE UNITED ARAB EMIRATES

Headlines
Prospects
Lack of Awareness of Sleep Aids Results in Low Demand
Population Focuses on Natural Methods To Encourage Sleep
Competitive Landscape
GlaxoSmithKline Leads, While Others Follow Distantly Within Sleep Aids
Competition for Sleep Aids From Prescriptions Is Expected To Continue
Category Data
Table 1 Sales of Sleep Aids: Value 2013-2018
Table 2 Sales of Sleep Aids: % Value Growth 2013-2018
Table 3 NBO Company Shares of Sleep Aids: % Value 2014-2018
Table 4 LBN Brand Shares of Sleep Aids: % Value 2015-2018
Table 5 Forecast Sales of Sleep Aids: Value 2018-2023
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2018-2023
Executive Summary
Consumer Health Records Negligible Recovery in 2018
Government Initiatives Complement Recovery
Introduction of 5% Value Added Tax Increases Preventive Medicine Costs
Chained Chemists/pharmacies Lead Distribution With Deals
Recovery Expected From Launch of New Health Care Institutions
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 1 Research Sources

Report Title: Sleep Aids in the United Arab Emirates


Your Details
Valid Invalid number

Related Report

Saudi Arabia Ophthalmic Equipment Market, By Product (Vision Care Products, Ophthalmology Surgical Devices, Diagnostic & Monitoring Devices, Others), By Application (Glaucoma, Amblyopia, Cataract, Retinal Detachment, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Ophthalmic Equipment Market, By Product (Vision Care Products, Ophthalmology Surgical Devices, Diagnostic & Monitoring Devices, Others), By Application (Glaucoma, Amblyopia, Cataract, Retinal Detachment, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Medical Devices Market, By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Company, By Region, Forecast & Opportunities, 2027

Saudi Arabia Medical Devices Market, By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Company, By Region, Forecast & Opportunities, 2027


Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-to-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems and Open MRI Systems), By Source (Domestic v/s Import), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-to-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems and Open MRI Systems), By Source (Domestic v/s Import), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Hospital Market, By Ownership (Public v/s Private), By Type (General, Specialty, Multi- Speciality), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds), By Region, Company Forecast & Opportunities, 2027

Saudi Arabia Hospital Market, By Ownership (Public v/s Private), By Type (General, Specialty, Multi- Speciality), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds), By Region, Company Forecast & Opportunities, 2027


Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027


SELECT A FORMAT

ADD TO CART BUY NOW